About
Contact & Profiles
Research Areas
- HIV/AIDS Research and Interventions
- HIV, Drug Use, Sexual Risk
- Adolescent Sexual and Reproductive Health
Background In sub-Saharan Africa (SSA), adolescent girls and young women (AGYW) ages 15 to 24 years represent <10% of the population yet account for 1 in 5 new HIV infections. Although oral pre-exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine (TDF/FTC) can be highly effective, low persistence PrEP programs poor adherence have limited its ability reduce incidence among women. Methods findings A total 336 AGYW participating PEPFAR-funded DREAMS program western...
10.1371/journal.pmed.1004097
article
EN
cc-by
PLoS Medicine
2022-09-12
Coming Soon ...